Literature DB >> 27346479

Primate liver tissue as an alternative substrate for endomysium antibody immunofluorescence testing in diagnostics of paediatric coeliac disease.

Johannes Wolf1, Annika Jahnke2, Kai Fechner2, Thomas Richter3, Martin W Laass4, Almuthe Hauer5, Martin Stern6, Jan de Laffolie7, Gunter Flemming8, Thomas Mothes9.   

Abstract

BACKGROUND: Immunofluorescence assays of antibodies against endomysium (EmA) on primate oesophagus sections represent the gold standard in serological testing for coeliac disease (CD). As alternative immunofluorescence technique, staining of primate liver tissue is in use. We compared performance and predictive power of IgA- and IgG-EmA on primate oesophagus and primate liver sections.
METHODS: Sera of 298 paediatric biopsy-proven CD patients under gluten-containing diet and 574 disease controls were investigated. Samples were collected between 2004 and 2013 in six children's hospitals. The antibodies were assayed blinded to diagnoses and histological data. Sensitivity, specificity, and positive (PPV) and negative predictive values (NPV) were calculated for different assays.
RESULTS: (Oesophagus vs liver): For IgA-EmA, sensitivity (0.953 vs 0.956) and specificity (0.981 vs 0.972) as well as PPV (0.963 vs 0.947) and NPV (0.976 vs 0.979) were comparable on both tissues. IgG-EmA on liver showed significantly higher sensitivity (0.520 vs 0.631; p=0.006) but significantly lower specificity (0.995 vs 0.963; p=0.002) and PPV (0.981 vs 0.899; p=0.0002) than on oesophagus. NPV on liver was higher than NPV on oesophagus, however, the difference was not statistically significant (0.799 vs 0.834; p=0.099).
CONCLUSION: Primate liver can be used as alternative, equally well functioning substrate for IgA-EmA testing.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Coeliac disease; Endomysium antibodies; Liver; Oesophagus; Serology

Mesh:

Substances:

Year:  2016        PMID: 27346479     DOI: 10.1016/j.cca.2016.06.023

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  2 in total

1.  Hemolysis and IgA-antibodies against tissue transglutaminase: When are antibody test results no longer reliable?

Authors:  Johannes Wolf; Norman Haendel; Johannes Remmler; Carl Elias Kutzner; Thorsten Kaiser; Thomas Mothes
Journal:  J Clin Lab Anal       Date:  2017-11-23       Impact factor: 2.352

Review 2.  Serological Biomarkers and Their Detection in Autoimmune Bullous Skin Diseases.

Authors:  Ilana Heckler; Michael Hong; Animesh Amart Sinha; Iswariya Venkataraman
Journal:  Dermatol Pract Concept       Date:  2022-04-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.